US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

ALTS Sigma Corporation

us-stock
To Invest in {{usstockname}}
us-stock
$1.58 0.0513(5.13%) ALTS at 04 Dec 2025 04:25 PM Software - Application
Lowest Today 1.49
Highest Today 1.64
Today’s Open 1.54
Prev. Close 1.56
52 Week High 10.95
52 Week Low 1.49
Day’s Range: Low 1.49 High 1.64
52-Week Range: Low 1.49 High 10.95
1 day return -
1 Week return -12.56
1 month return -20.43
3 month return -57.47
6 month return -83.23
1 year return -41.18
3 year return -
5 year return -
10 year return -

Institutional Holdings

Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 238.65 M

PB Ratio 24.1521

PE Ratio 0.0

Enterprise Value 240.30 M

Total Assets 82.44 M

Volume 4145868

Company Financials

Fund house & investment objective

Company Information ALT5 Sigma Corporation, together with its subsidiaries, provides blockchain-powered technologies worldwide. It operates through Fintech and Biotechnology segments. The company engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. Its products include ALT 5 Prime, an electronic over-the-counter trading platform for the buying and selling of digital assets; and ALT 5 Pay, a crypto-currency payment gateway that enables merchants to accept and make crypto currency payments or integrate the payment platform into their application. The company is also involved identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies for the treatment of pain and addiction. In addition, it develops JAN 101, an oral and sustained-release pharmaceutical composition of sodium nitrite that has completed Phase 2a clinical trial to treat peripheral arterial disease and pain; and JAN123, a formulation of low-dose naltrexone for the treatment of chronic regional pain syndrome. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.

Organisation Software - Application

Employees 10

Industry Software - Application

CEO Mr. Jonathan Hugh

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right